Cattle producers have long recognized the need for proper husbandry and stewardship, given the intensive animal husbandry model that currently houses a majority of cattle reared each year. Growing beef production and increasing demand for animal protein in an era of ever stricter regulations for rearing and food safety testing will have a positive impact on the cattle healthcare market. Health consciousness is an increasing concern and as Americans attempt to eat healthier food, producers respond and new products are appearing in the marketplace - and beef is no exception.
Statistics shows that in 2013, global cattle population was estimated to be 1485.2 million and with increasing awareness for cattle healthcare, number is expected to increase further which in turn will propel cattle healthcare market to grow.
In a country wise analysis it is seen that emerging markets such as Eastern Europe, Latin America and Asia are witnessing an increase in share because of the increasing importance given to animal health by the livestock breeders. As these regions are showing very strong economic growth in recent past years, livestock breeders are giving due importance to management of cattle health to cater to the growing nutritional needs of population. In developed countries market will be stagnant in coming years because of less consumption of cattle meat and dairy products.
Major company players are looking at the entire cattle healthcare ecosystem to maximize value for farmers. Creating value in addition to the products and services that firms offer has been a key strategy. The E=P+S program, for instance, helps farmers become profitable while keeping their operations sustainable given more discriminating preferences of end-consumers.
In this report, the market is segmented by type of disease into vaccines, Paraciticides, Anti-Infectives; Medicinal feed additives, and other pharmaceuticals. The market is further segmented by diagnostics -Enzyme Linked Sorbent Assay (ELISA), Rapid Immuno migration (RIM), and Agar Gel Immuno diffusion (AGID), and genetics. Regional markets analyzed in this report are North America, Europe, Asia-Pacific and the rest ofthe world (Row).
What the report offers
Reasons for buying this report